Theodore M. Sullivan, Partner

Publications and Presentations

11/11/20 – Newsletter

Susan Brichler Trujillo

The FDA Announces Delays in DSCSA Compliance Requirements and Issues Final Version of Compounding Drug Memorandum of UnderstandingHealth & Life SciencesSusan B. Trujillo, Theodore M. SullivanIn October, the Food and Drug Administration (FDA) released guidance documents affecting wholesale distributors, state boards of pharmacy and compounding pharmacies. First, FDA issued a Compliance Policy (the 2020 Compliance Policy) delaying the enforcement of certain requirements of the Drug... Read More

09/29/20 – Newsletter Importation of Pharmaceuticals From Canada Under the Section 804 Importation Program Health & Life Sciences Alert Theodore M. Sullivan

12/02/19 – Newsletter Second Shot Across the Bow: FDA Issues Warning Letters to 15 CBD Companies Health & Life Sciences Alert Roger Morris, Ted Sullivan, Nicholas H. Meza

07/25/19 – Newsletter FDA Takes Action Against Curaleaf for Misbranded CBD Products Health & Life Sciences Alert Theodore M. Sullivan

07/20/17 – Presentation "Compounding Pharmacy Perspectives" Quarles & Brady Pharmacy Law Symposium Edward D. Rickert, Theodore M. Sullivan

08/25/16 – Newsletter A Reminder to our Friends in the Food Distribution Industry: Compliance Dates for FDA Food Safety Regulations Fast Approaching Health Law Alert Theodore M. Sullivan